From Yahoo Finance: 2025-06-04 08:33:00

Biotech funding has dropped significantly due to Trump administration policies, with May funding down 57% from last year. Jefferies analysts attribute the decline to proposed budget cuts and regulatory uncertainties. This environment is challenging for biotech companies, leading some to liquidate. Venture capital funding has fared better than public markets, but uncertainty looms. 1. The stock market saw a significant increase today, with the Dow Jones Industrial Average rising 300 points. This surge was driven by positive earnings reports from several major companies, including Apple and Amazon.

2. In world news, tensions continue to escalate between Russia and Ukraine as Russian troops gather near the border. The United States and European Union have expressed concerns over the potential for further conflict in the region.

3. COVID-19 cases are on the rise in several states in the U.S., leading to renewed calls for increased vaccination efforts. Health officials are urging the public to follow safety guidelines and get vaccinated to help curb the spread of the virus.

4. A new study suggests that a plant-based diet may be more effective in reducing the risk of heart disease than a diet that includes animal products. Researchers found that participants who followed a plant-based diet had lower levels of cholesterol and blood pressure.

5. The Tokyo Olympics are set to begin in less than a month, but concerns are mounting over the safety of holding the event during the ongoing pandemic. Organizers have implemented strict COVID-19 protocols to protect athletes and spectators.

Read more: Biotech funding plummets as Trump policies unnerve investors: Jefferies